VISTAGEN THERAPEUTICS, INC.

Transcripts Vistagen Therapeutics, Inc.

Equities

VTGN

US92840H4002

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-23 pm EDT			5-day change	1st Jan Change
4.1 ^USD	-3.76%		-9.89%	-20.23%

May. 23	Vistagen Therapeutics, Inc. to Present At the 2024 American Society of Clinical Psychopharmacology Conference	CI
Apr. 25	Vistagen Announces Positive Results from Phase 2A Pilot Study of Ph15 for Improvement of Psychomotor Impairment Caused by Mental Fatigue	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Vistagen Therapeutics, Inc., Q3 2024 Earnings Call, Feb 13, 2024	Feb. 13
Transcript : Vistagen Therapeutics, Inc., Q2 2024 Earnings Call, Nov 09, 2023	Nov. 09
Transcript : Vistagen Therapeutics, Inc., Q1 2024 Earnings Call, Aug 10, 2023	23-08-10
Transcript : Vistagen Therapeutics, Inc., 2023 Earnings Call, Jun 28, 2023	23-06-28
Transcript : VistaGen Therapeutics, Inc., Q3 2023 Earnings Call, Feb 07, 2023	23-02-07
Transcript : VistaGen Therapeutics, Inc., Q2 2023 Earnings Call, Nov 10, 2022	22-11-10
Transcript : VistaGen Therapeutics, Inc. Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-13-2022 11:45 AM	22-09-13
Transcript : VistaGen Therapeutics, Inc., Q1 2023 Earnings Call, Aug 11, 2022	22-08-11
Transcript : VistaGen Therapeutics, Inc., 2022 Earnings Call, Jun 23, 2022	22-06-23
Transcript : VistaGen Therapeutics, Inc., Q3 2022 Earnings Call, Feb 10, 2022	22-02-10

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer